Phil DiGiacomo joined NanoDimension as a part-time associate in 2016. He focuses on life science investments.
Phil is currently completing his PhD at Stanford University in Bioengineering, where he works on identifying and developing novel imaging-based biomarkers and therapeutic targets for neurodegenerative diseases. He is a SPARK Translational Research Fellow and Training in Biomedical Imaging and Instrumentation Fellow. Phil has a Masters of Medicine from the Stanford University School of Medicine and holds a dual bachelor’s degree in Mathematics and Cognitive Science from the University of Virginia.